Effects of some sympathomimetic drugs and their antagonists on afterdischarges elicited in chronically isolated slabs of cerebral cortex.
1. The role of sympathomimetic agents in the maintenance and termination of induced cortical epileptiform activity was studied in chronically neuronally isolated slabs of cerebral cortex in the suprasylvian gyrus of unanaesthetized, unrestrained cats.2. The administration of the sympathomimetic agents (+)-amphetamine, methamphetamine, tyramine, and ephedrine resulted in a highly significant decrease in the duration of epileptiform afterdischarge (EADs).3. The alpha-adrenoceptor blocking drugs phenoxybenzamine, phentolamine and tolazoline did not significantly alter the duration of EADs but prevented the decrease in duration of EADs produced by the sympathomimetic drugs.4. The effect of atropine and arecoline on the duration of EADs, previously described, were not modified by the alpha-adrenoceptor blocking drugs, but atropine prevented and reversed the inhibitory action of amphetamine.5. It is suggested that (1) in the chronically neuronally isolated cortical slab there is normally no spontaneous adrenergic activity, (2) a cortical, cholinergic inhibitory mechanism, previously described, is modulated by ascending adrenergic influences, (3) adrenergic cholinergic linkages might be arranged in the cortex in an alternating network, as proposed by Feldberg.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects* / Q000503:physiopathology; D004558:Electric Stimulation; D004594:Electrophysiology / Q000187:drug effects; D004809:Ephedrine / Q000494:pharmacology; D005260:Female; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D013997:Time Factors; D014043:Tolazoline / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D008694:Methamphetamine; D001115:Arecoline; D001285:Atropine; D014043:Tolazoline; D000661:Amphetamine; D004809:Ephedrine; D014439:Tyramine; D010646:Phentolamine